The first one, available on the CMS' Hospital Compare website, measures the use of cardiac imaging for preoperative risk assessment in patients undergoing noncardiac low-risk surgery, such as endoscopy.
Such imaging is widely considered to be unnecessary, as well as a major driver of ballooning medical costs, said Janet Young, a lead scientist at Truven and the principal investigator of the Cardiovascular Benchmarks report.
Indeed, the American College of Cardiology cautioned against routine cardiac imaging for noncardiac low-risk surgeries as part of its contribution to Choosing Wisely.
Led by the Washington-based ABIM Foundation, affiliated with the American Board of Internal Medicine, Choosing Wisely partners with medical societies, each of which contributes a list of five commonly ordered but usually unnecessary—and sometimes harmful—tests and procedures, based on available evidence. The ACC was among the first nine medical societies to release top-five lists when the initiative launched in April 2012.
“We aligned ourselves with Choosing Wisely because it addressed how you explain to patients that sometimes less is more,” said Dr. William Zoghbi, the ACC's immediate past president.
As of last week, the number of medical societies participating in the initiative has grown to 58.
Truven's second new measure, Young said, looks at hospitals' use of bilateral cardiac catheterization in patients with coronary artery disease.
Most patients with coronary artery disease need only left-sided cardiac catheterization unless they have some other additional conditions, Young said, adding that bilateral cardiac catheterizations are more costly and introduce additional risks, such as infection.
“As we continue to try to differentiate hospitals, we're looking to expand what we're able to measure,” she said. “These metrics go beyond the areas that we have looked at before.”
Truven gathered data on the two new measures for this latest report but did not use them in determining this year's 50 top cardiovascular hospitals, said Jean Chenoweth, senior vice president of performance improvement at Truven. They will be included next year, she predicted, barring any legitimate concerns from hospitals.
“The trend for care is moving toward balancing cost and quality, and we need to be measuring along those lines,” Chenoweth said. “We're changing our methodology, but we want to give people in the field time to provide feedback.”
Now in its 15th year, Truven's list of top cardiovascular hospitals recognizes 50 high-performing hospitals from a field of more than 1,000, based on performance across measures of cardiovascular safety, quality and efficiency, including mortality, 30-day readmission rates and whether hospitals followed evidence-based practices, such as providing instructions at discharge (See chart, p. 22).
Truven released its 50 Top Cardiovascular Hospitals list exclusively to Modern Healthcare.